Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)

Clinical trial NCT07600983 · RECRUITING

Trial details

NCT number: NCT07600983
Sponsor: CanSino Biologics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Streptococcus Pneumoniae Infection

Start date: 2026-05-24
Primary completion: 2026-11-24
Enrollment: 854

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.